Patents by Inventor Robert M. Keenan

Robert M. Keenan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal nicotine metabolites and human body weight
    Patent number: 5972974
    Abstract: A therapeutic method is provided to manage human body weight in nicotine-experienced or nicotine-naive individuals, comprising of transdermally administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in need of such treatment, in an amount which is effective to manage human body weight.
    Type: Grant
    Filed: November 7, 1996
    Date of Patent: October 26, 1999
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventor: Robert M. Keenan
  • Nicotine-free smoking material
    Patent number: 5880164
    Abstract: A smoking material is provided that is useful to alleviate the symptoms of the tobacco withdrawal syndrome comprising an amount of continine or a pharmaceutical acceptable salt thereof in combination with a non-toxic vegetable material, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome in a human when the smoking material is smoked by a human.
    Type: Grant
    Filed: October 3, 1996
    Date of Patent: March 9, 1999
    Assignee: LecTec Corporation
    Inventor: Robert M. Keenan
  • Nicotine metabolites and nicotine dependence
    Patent number: 5869505
    Abstract: A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in need of such treatment, in an amount which is effective to reduce or eliminate at least one of the symptoms of the tobacco withdrawal syndrome, nicotine withdrawal or manage human body weight.
    Type: Grant
    Filed: February 2, 1993
    Date of Patent: February 9, 1999
    Inventor: Robert M. Keenan
  • Nicotine metabolites and human body weight
    Patent number: 5869503
    Abstract: A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in need of such treatment, in an amount which is effective to reduce or eliminate at least one of the symptoms of the tobacco withdrawal syndrome, nicotine withdrawal or manage human body weight.
    Type: Grant
    Filed: May 2, 1994
    Date of Patent: February 9, 1999
    Inventor: Robert M. Keenan
  • Use of cotinine to alleviate tobacco withdrawal syndrome
    Patent number: 5747512
    Abstract: A therapeutic method is provided to alleviate tobacco withdrawal syndrome and/or the symptoms of nicotine withdrawal, comprising administering an amount of cotinine or a pharmaceutically acceptable salt thereof to a human in need of such treatment, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome or nicotine withdrawal.
    Type: Grant
    Filed: August 1, 1996
    Date of Patent: May 5, 1998
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventors: Robert M. Keenan, Dorothy K. Hatsukami
  • Human body weight management
    Patent number: 5643928
    Abstract: A therapeutic method and article of manufacture to manage human body weight with the use of cotinine or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: July 1, 1997
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventor: Robert M. Keenan
  • Use of cotinine to assist in the cessation of tobacco smoking
    Patent number: 5612357
    Abstract: A pharmaceutical composition is provided that is useful to alleviate various symptoms of tobacco withdrawal syndrome comprising an amount of cotinine or a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome in a human.
    Type: Grant
    Filed: August 22, 1994
    Date of Patent: March 18, 1997
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventors: Robert M. Keenan, Dorothy K. Hatsukami
  • Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
    Patent number: 5596007
    Abstract: A therapeutic method is provided to alleviate tobacco withdrawal syndrome and/or the symptoms of nicotine withdrawal, comprising administering an amount of cotinine or a pharmaceutically acceptable salt thereof to a human in need of such treatment, which amount is effective to reduce or eliminate at least one of the symptoms of tobacco withdrawal syndrome or nicotine withdrawal.
    Type: Grant
    Filed: May 18, 1992
    Date of Patent: January 21, 1997
    Assignee: Pharmaco Behavioral Associates, Inc.
    Inventors: Robert M. Keenan, Dorothy K. Hatsukami
  • Nicotine metabolites, nicotine dependence and human body weight
    Patent number: 5573774
    Abstract: A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in need of such treatment, in an amount which is effective to reduce or eliminate at least one of the symptoms of the tobacco withdrawal syndrome, nicotine withdrawal or manage human body weight.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 12, 1996
    Inventor: Robert M. Keenan